Opinion: Pharma and biotech should embrace ‘Medicare for all,’ not defeat it
Instead of opposing every "Medicare for all" proposal, the #pharma and #biotech industries need to help guide Washington toward a future made inevitable by their own astonishing discoveries.
As a growing pantheon of Democratic politicians pledge their support for “Medicare for all” and its variants, the pharmaceutical and biotechnology industries are gearing up for an epic and expensive battle to kill these proposals.
As someone who has worked at the highest levels of the pharmaceutical and biotechnology industries, I think this opposition is a huge mistake.
Without a greater government role in health insurance, many of the discoveries emerging from the labs of these industries will never reach
